Medical Gases Subsidiary Transfers to Leading Supplier

NOxBOX® Ltd, a successful medical gases subsidiary created by parent company Bedfont® Scientific Ltd,  has been sold to the UK branch of Praxair, a Fortune 250 company with 2015 sales of $11 billion and one of the largest industrial gas companies worldwide. Financial terms of the transaction were not disclosed.  The sale includes the full NOxBOX range of critical care delivery and monitoring devices for inhaled nitric oxide therapy which have been globally available in different forms since 1997.

Bedfont’s Managing Director, Trevor Smith, reported, “This transaction will allow our company to focus on its core business in diagnostics using exhaled breath analysis which we see as a tremendous opportunity in the future. Our NOxBOX range of products will much better be supported by Praxair, a global industrial and medical gas company.”
It is expected that the transfer of ownership will be largely seamless with a “business as usual” approach. The NOxBOX Ltd company will continue to be located in the UK and staff members previously involved are transferring with the business.

A leading manufacturer of exhaled breath and gas monitoring instruments, Bedfont is celebrating two important anniversaries – 40 years in business and 30 years of one of its most successful exports – the Smokerlyzer®.